Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort. Chougnet, C. N.; Borget, I.; Leboulleux, S.; de la Fouchardiere, C.; Bonichon, F.; Criniere, L.; Niccoli, P.; Bardet, S.; Schneegans, O.; Zanetta, S.; Schvartz, C.; Drui, D.; Chauffert, B.; Rohmer, V.; Schlumberger, M.. Thyroid. 2015; 386-91: p.386-91. doi:10.1089/thy.2014.0361 10.1089/thy.2014.0361. Epub 2015 Feb 18.Article
Oncostat